Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS.

Wu J, Xie X, Liu Y, He J, Benitez R, Buckanovich RJ, Lubman DM.

J Proteome Res. 2012 Sep 7;11(9):4541-52. doi: 10.1021/pr300330z. Epub 2012 Aug 6.

PMID:
22827608
2.

A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.

Narimatsu H, Sawaki H, Kuno A, Kaji H, Ito H, Ikehara Y.

FEBS J. 2010 Jan;277(1):95-105. doi: 10.1111/j.1742-4658.2009.07430.x. Epub 2009 Nov 17. Review.

3.

Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis.

Saldova R, Wormald MR, Dwek RA, Rudd PM.

Dis Markers. 2008;25(4-5):219-32. Review.

4.

Cancer biomarker discovery: lectin-based strategies targeting glycoproteins.

Clark D, Mao L.

Dis Markers. 2012;33(1):1-10. doi: 10.3233/DMA-2012-0904. Review.

5.

Lectin-based glycoproteomic techniques for the enrichment and identification of potential biomarkers.

Abbott KL, Pierce JM.

Methods Enzymol. 2010;480:461-76. doi: 10.1016/S0076-6879(10)80020-5. Review.

PMID:
20816222
6.

Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers.

Badr HA, Alsadek DM, Darwish AA, Elsayed AI, Bekmanov BO, Khussainova EM, Zhang X, Cho WC, Djansugurova LB, Li CZ.

Expert Rev Proteomics. 2014 Apr;11(2):227-36. doi: 10.1586/14789450.2014.897611. Epub 2014 Mar 10. Review.

PMID:
24611567
7.

Defining glycoprotein cancer biomarkers by MS in conjunction with glycoprotein enrichment.

Song E, Mechref Y.

Biomark Med. 2015;9(9):835-44. doi: 10.2217/bmm.15.55. Epub 2015 Sep 2. Review.

8.

Comparative glycoproteomics: approaches and applications.

Wei X, Li L.

Brief Funct Genomic Proteomic. 2009 Mar;8(2):104-13. doi: 10.1093/bfgp/eln053. Epub 2008 Dec 17. Review.

9.

Cancer serum biomarkers based on aberrant post-translational modifications of glycoproteins: Clinical value and discovery strategies.

Silva ML.

Biochim Biophys Acta. 2015 Dec;1856(2):165-77. doi: 10.1016/j.bbcan.2015.07.002. Epub 2015 Jul 30. Review.

PMID:
26232626
10.

Sweetening the pot: adding glycosylation to the biomarker discovery equation.

Drake PM, Cho W, Li B, Prakobphol A, Johansen E, Anderson NL, Regnier FE, Gibson BW, Fisher SJ.

Clin Chem. 2010 Feb;56(2):223-36. doi: 10.1373/clinchem.2009.136333. Epub 2009 Dec 3. Review.

11.

Characterization of disease-associated N-linked glycoproteins.

Tian Y, Zhang H.

Proteomics. 2013 Feb;13(3-4):504-11. doi: 10.1002/pmic.201200333. Review.

12.

Afamin--A pleiotropic glycoprotein involved in various disease states.

Dieplinger H, Dieplinger B.

Clin Chim Acta. 2015 Jun 15;446:105-10. doi: 10.1016/j.cca.2015.04.010. Epub 2015 Apr 16. Review.

13.

Application of cancer-associated glycoforms and glycan-binding probes to an in vitro diagnostic multivariate index assay for precise diagnoses of cancer.

Kang JG, Ko JH, Kim YS.

Proteomics. 2016 Dec;16(24):3062-3072. doi: 10.1002/pmic.201500553. Epub 2016 May 11. Review.

Supplemental Content

Support Center